Concepedia

Peter W. Fan

PW

31

Publications

1.3K

Citations

22

H-Index

1998

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Amgen (United States)

University of Illinois Chicago

Gilead Sciences (United States)

Daiichi-Sankyo (Japan)

Peter W. Fan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1998–2022

31

Publications

31

Characterization of Raloxifene Glucuronidation in Vitro: Contribution of Intestinal Metabolism to Presystemic Clearance

Daniel C. Kemp, Peter W. Fan, Jeffrey Stevens · Drug Metabolism and Disposition · 2002 · 191 citations

NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus

Hans D. Brightbill, Eric Suto, Nicole Blaquière et al. · Nature Communications · 2018 · 120 citations · Full text

4-Hydroxylated Metabolites of the Antiestrogens Tamoxifen and Toremifene Are Metabolized to Unusually Stable Quinone Methides

Peter W. Fan, Fagen Zhang, Judy L. Bolton · Chemical Research in Toxicology · 1999 · 99 citations

, , +22

Characterization of Differential Tissue Abundance of Major Non-CYP Enzymes in Human

Abdul Basit, Naveen K. Neradugomma, Christopher C. Wolford et al. · Molecular Pharmaceutics · 2020 · 82 citations

, , +23

Synthesis and Reactivity of a Potential Carcinogenic Metabolite of Tamoxifen:  3,4-Dihydroxytamoxifen-<i>o</i>-quinone

Fagen Zhang, Peter W. Fan, Xuemei Liu et al. · Chemical Research in Toxicology · 1999 · 78 citations

, , +15

Rows per page

1–5 of 31